Publications by authors named "D Chatel"
Article Synopsis
- A study comparing aortic valve repair and replacement in patients with aortic root aneurysm showed no significant differences in overall patient outcomes up to 4 years, although repairs slightly favored fewer valve-related deaths and major bleeding incidents.
- The multicentric CAVIAAR study included 261 patients, with 130 receiving valve repair and 131 receiving valve replacement, measuring various adverse events and outcomes after the procedures.
- Despite similar primary outcomes, repair patients experienced a notable decrease in certain complications, suggesting potential benefits of valve repair that warrant further long-term research.
Article Synopsis
- The objective of this text is to recommend strategies for enhanced recovery after cardiac surgery (ERACS) using a comprehensive approach aimed at improving patient satisfaction, reducing mortality and morbidity, and decreasing hospital stays.
- A consensus of 20 experts from French medical societies developed these guidelines independently without industry influence, utilizing the GRADE system to evaluate the quality of evidence.
- The guidelines cover six key areas of patient care, leading to 33 specific recommendations focused on improving preoperative, surgical, and postoperative management for cardiac surgery patients.
Objective: The study objective was to compare the 30-day outcomes of a standardized aortic valve repair technique (REPAIR group) associating root remodeling with an expansible aortic ring annuloplasty versus mechanical composite valve and graft (CVG group) replacement in treating aortic root aneurysms.
Methods: A total of 261 consecutive patients with aortic root aneurysm were enrolled in this multicentric prospective cohort (131 in the CVG group, 130 in the REPAIR group) in 20 centers. The main end point is a composite criterion including mortality; reoperation; thromboembolic, hemorrhagic, or infectious events; and heart failure.
Dual antiplatelet therapy is commonly used in patients undergoing transcatheter aortic valve implantation (TAVI), but the optimal antiplatelet regimen is uncertain and remains to be determined. The objective of this study was to compare 2 strategies of antiplatelet therapy in patients undergoing TAVI. A strategy using monoantiplatelet therapy (group A, n = 164) was prospectively compared with a strategy using dual antiplatelet therapy (group B, n = 128) in 292 consecutive patients undergoing TAVI.
View Article and Find Full Text PDF